权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Mouse Models of NMDAR Hypofunction

NMDAR 功能减退小鼠模型

基本信息

批准号：
8074008
负责人：
JOSEPH T. COYLE
金额：
$ 30.45万
依托单位：
MCLEAN HOSPITAL
依托单位国家：
美国
项目类别：
财政年份：
2010
资助国家：
美国
起止时间：
2010-06-01 至 2011-05-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8074008
关键词：
Affect Agonist Alzheimer&apos s Disease Astrocytes Behavior Behavioral Brain Cells Chemistry Clozapine Code Cognitive Cognitive deficits Collaborations Complementary DNA Cycloserine D-Amino Acid Dehydrogenase Dopamine D2 Receptor Electrophysiology (science)Enhancers Genes Genetic Genomics Glial Fibrillary Acidic Protein Glutamate Carboxypeptidase II Glutamates Glycine Haloperidol High Pressure Liquid Chromatography Hippocampus (Brain)Human Activities Impaired cognition In Vitro Measurement Measures Modeling Mus Mutant Strains Mice Mutation N-Methyl-D-Aspartate Receptors N-acetylaspartate N-acetylaspartylglutamate Pathology Patients Pharmaceutical Preparations Physiology Plasma Proteins Recombinants Reporting Risk Role Sarcosine Schizophrenia Serine Site Synapses Techniques Tetracyclines Transgenic Mice Transgenic Organisms Ursidae Family Variant adeno-associated viral vector in vivo inhibitor/antagonist link protein metabotropic glutamate receptor 3 mouse model mutant neurochemistry novel promoter protein expression psychopharmacologic receptor function research study serine racemase tissue culture

项目摘要

Genetic, post-mortem and psychopharmacologic findings support the hypothesis that hypofunction of NMDA receptors may contribute symptomatic manifestations of schizophrenia. One potential mechanism is through the glycine modulatory site on the NMDA receptor, which must be occupied by glycine/D-serine, for the NMDA receptor to function. The association of the risk for schizophrenia with the gene encoding G72, a protein that activates D-amino acid oxidase that degrades D-serine, suggests low D-serine, which has been reported in schizophrenia, could be one cause of NMDA receptor hypofunction. To understand better the role of D-serine in hippocampal physiology and behavior, we will pursue two strategies. First, we will use our mice with floxed serine racemase gene to suppress its expression at 4 weeks pot-partum and characterize the neurophysiologic and behavioral consequences. Secondly, we will characterize the effects of transfected G72 on D-amino acid oxidase activity and D-serine levels in vitro, in tissue culture and in vivo using transgenic techniques. Finally, N-acetyl aspartyl glutamate (NAAG) is catabolized by glutamate Carboxypeptidase II (GCPII). NAAG is a selective agonist at mGluR3 (GRM3), whose gene has been associated with risk for schizophrenia; and GCPII expression is reduced in schizophrenia. We will use our mice with floxed GCPII to suppress its expression at 4 weeks post-partum and characterize the neurophysiologic and behavioral consequences. We believe that these experiments should provide informative mutant mice that should share homologies in behavior and synaptic chemistry to schizophrenia and will permit correlating cognitive deficits defined by the same tasks in patients and mice to hippocampal electrophysiology.

遗传、尸检和精神药理学研究结果支持NMDA功能减退的假说，受体可能有助于精神分裂症的症状表现。一个潜在的机制是通过 NMDA受体上的甘氨酸调节位点，其必须被甘氨酸/D-丝氨酸占据，用于 NMDA受体的功能。精神分裂症的风险与G72基因编码的关联，一种激活降解D-丝氨酸的D-氨基酸氧化酶的蛋白质，表明D-丝氨酸含量低，在精神分裂症中报道，可能是NMDA受体功能低下的原因之一。更好地了解为了研究D-丝氨酸在海马生理和行为中的作用，我们将采取两种策略。首先，我们将使用我们的在产后4周时用floxed丝氨酸消旋酶基因抑制其表达的小鼠，并表征神经生理和行为后果。其次，我们将描述转染的 G72对D-氨基酸氧化酶活性和D-丝氨酸水平的影响转基因技术最后，N-乙酰基谷氨酸酯（NAAG）被谷氨酸分解代谢羧肽酶II（GCPII）。NAAG是mGluR 3（GRM 3）的选择性激动剂，其基因已被发现。与精神分裂症的风险相关;并且GCPII表达在精神分裂症中降低。我们将用我们在产后4周时用floxed GCPII抑制其表达，并表征神经生理和行为后果。我们认为这些实验应该提供信息突变小鼠应该与精神分裂症在行为和突触化学方面具有同源性并将允许将患者和小鼠相同任务定义的认知缺陷与海马体关联起来电生理学